clinical trial · NCT06878170
A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
Rock BioMedical, Inc.·phase1·active not recruiting·n = 60
COVID-19RBM-001
brief summary
A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers
started
Sep 30, 2024
primary completion
May 30, 2025
completion
Jan 30, 2026
last updated
Aug 8, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol